266 related articles for article (PubMed ID: 31758608)
1. GTF2IRD1 on chromosome 7 is a novel oncogene regulating the tumor-suppressor gene TGFβR2 in colorectal cancer.
Nambara S; Masuda T; Kobayashi Y; Sato K; Tobo T; Koike K; Noda M; Ogawa Y; Kuroda Y; Ito S; Eguchi H; Sugimachi K; Mimori K
Cancer Sci; 2020 Feb; 111(2):343-355. PubMed ID: 31758608
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic splicing abnormalities induced by DEAD-Box Helicase 56 amplification in colorectal cancer.
Kouyama Y; Masuda T; Fujii A; Ogawa Y; Sato K; Tobo T; Wakiyama H; Yoshikawa Y; Noda M; Tsuruda Y; Kuroda Y; Eguchi H; Ishida F; Kudo SE; Mimori K
Cancer Sci; 2019 Oct; 110(10):3132-3144. PubMed ID: 31390121
[TBL] [Abstract][Full Text] [Related]
3. GTF2IRD1 overexpression promotes tumor progression and correlates with less CD8+ T cells infiltration in pancreatic cancer.
Zhuang H; Zhang C; Hou B
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32936232
[TBL] [Abstract][Full Text] [Related]
4. Phosphoserine Phosphatase Is a Novel Prognostic Biomarker on Chromosome 7 in Colorectal Cancer.
Sato K; Masuda T; Hu Q; Tobo T; Kidogami S; Ogawa Y; Saito T; Nambara S; Komatsu H; Hirata H; Sakimura S; Uchi R; Hayashi N; Iguchi T; Eguchi H; Ito S; Nakagawa T; Mimori K
Anticancer Res; 2017 May; 37(5):2365-2371. PubMed ID: 28476802
[TBL] [Abstract][Full Text] [Related]
5. Lysyl oxidase: A colorectal cancer biomarker of lung and hepatic metastasis.
Liu Y; Wang G; Liang Z; Mei Z; Wu T; Cui A; Liu C; Cui L
Thorac Cancer; 2018 Jul; 9(7):785-793. PubMed ID: 29766649
[TBL] [Abstract][Full Text] [Related]
6. Novel oncogene 5MP1 reprograms c-Myc translation initiation to drive malignant phenotypes in colorectal cancer.
Sato K; Masuda T; Hu Q; Tobo T; Gillaspie S; Niida A; Thornton M; Kuroda Y; Eguchi H; Nakagawa T; Asano K; Mimori K
EBioMedicine; 2019 Jun; 44():387-402. PubMed ID: 31175057
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of Prognostic and Genetic Signatures for General Transcription Factor III (GTF3) in Clinical Colorectal Cancer Patients Using Bioinformatics Approaches.
Anuraga G; Tang WC; Phan NN; Ta HDK; Liu YH; Wu YF; Lee KH; Wang CY
Curr Issues Mol Biol; 2021 Apr; 43(1):2-20. PubMed ID: 33925358
[TBL] [Abstract][Full Text] [Related]
8. A novel amplification gene PCI domain containing 2 (PCID2) promotes colorectal cancer through directly degrading a tumor suppressor promyelocytic leukemia (PML).
Zhang J; Zhai J; Wong CC; Chen H; Wang X; Ji J; Yu J
Oncogene; 2021 Dec; 40(49):6641-6652. PubMed ID: 34625711
[TBL] [Abstract][Full Text] [Related]
9. A novel long non-coding RNA lnc-GNAT1-1 is low expressed in colorectal cancer and acts as a tumor suppressor through regulating RKIP-NF-κB-Snail circuit.
Ye C; Shen Z; Wang B; Li Y; Li T; Yang Y; Jiang K; Ye Y; Wang S
J Exp Clin Cancer Res; 2016 Dec; 35(1):187. PubMed ID: 27912775
[TBL] [Abstract][Full Text] [Related]
10. Pro-inflammatory TNF-α and IFN-γ Promote Tumor Growth and Metastasis via Induction of MACC1.
Kobelt D; Zhang C; Clayton-Lucey IA; Glauben R; Voss C; Siegmund B; Stein U
Front Immunol; 2020; 11():980. PubMed ID: 32670264
[TBL] [Abstract][Full Text] [Related]
11. Karyopherin β1 deletion suppresses tumor growth and metastasis in colorectal cancer (CRC) by reducing MET expression.
Zhang Y; Li KF
Biomed Pharmacother; 2019 Dec; 120():109127. PubMed ID: 31629952
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer.
Ueda M; Iguchi T; Nambara S; Saito T; Komatsu H; Sakimura S; Hirata H; Uchi R; Takano Y; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1490-8. PubMed ID: 26036188
[TBL] [Abstract][Full Text] [Related]
13. ITGBL1 promotes migration, invasion and predicts a poor prognosis in colorectal cancer.
Qiu X; Feng JR; Qiu J; Liu L; Xie Y; Zhang YP; Liu J; Zhao Q
Biomed Pharmacother; 2018 Aug; 104():172-180. PubMed ID: 29772438
[TBL] [Abstract][Full Text] [Related]
14. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
[No Abstract] [Full Text] [Related]
15. Overexpression of ZNF169 promotes the growth and proliferation of colorectal cancer cells via the upregulation of ANKZF1.
Zhang J; Wang Y; Hou S; Chi X; Ding D; Xue M; Zhang M; Wang J; Shuai J; Sun H; Gao Q; Kang C
Oncol Rep; 2024 Jun; 51(6):. PubMed ID: 38666541
[TBL] [Abstract][Full Text] [Related]
16. A novel lncRNA NR4A1AS up-regulates orphan nuclear receptor NR4A1 expression by blocking UPF1-mediated mRNA destabilization in colorectal cancer.
Xie X; Lin J; Liu J; Huang M; Zhong Y; Liang B; Song X; Gu S; Chang X; Huang D; Tang A
Clin Sci (Lond); 2019 Jul; 133(13):1457-1473. PubMed ID: 31253658
[TBL] [Abstract][Full Text] [Related]
17. LncRNA CASC9 interacts with CPSF3 to regulate TGF-β signaling in colorectal cancer.
Luo K; Geng J; Zhang Q; Xu Y; Zhou X; Huang Z; Shi KQ; Pan C; Wu J
J Exp Clin Cancer Res; 2019 Jun; 38(1):249. PubMed ID: 31186036
[TBL] [Abstract][Full Text] [Related]
18. An In Vivo Gain-of-Function Screen Identifies the Williams-Beuren Syndrome Gene GTF2IRD1 as a Mammary Tumor Promoter.
Huo Y; Su T; Cai Q; Macara IG
Cell Rep; 2016 Jun; 15(10):2089-2096. PubMed ID: 27239038
[TBL] [Abstract][Full Text] [Related]
19. Nuclear division cycle 80 promotes malignant progression and predicts clinical outcome in colorectal cancer.
Yan X; Huang L; Liu L; Qin H; Song Z
Cancer Med; 2018 Feb; 7(2):420-432. PubMed ID: 29341479
[TBL] [Abstract][Full Text] [Related]
20. Linc00659, a long noncoding RNA, acts as novel oncogene in regulating cancer cell growth in colorectal cancer.
Tsai KW; Lo YH; Liu H; Yeh CY; Chen YZ; Hsu CW; Chen WS; Wang JH
Mol Cancer; 2018 Mar; 17(1):72. PubMed ID: 29523145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
